FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2075407107> ?p ?o ?g. }

• W2075407107 endingPage "165" @default.
• W2075407107 startingPage "150" @default.
• W2075407107 abstract "At present, mammary carcinoma is the second most common type of malignant tumor in adult women after lung cancer, as more than one million women are diagnosed with breast cancer every year. Despite advances in diagnosis and treatment, which have resulted in a decrease in mortality in recent decades, breast cancer remains a major public health problem. One of the most significant unresolved clinical and scientific problems is the occurrence of resistance to clinical treatments and their toxicity (and how to predict, prevent and overcome them). However, the heterogeneity of human breast cancer in terms of genetic features, molecular profiles and clinical behavior represents a constraint obstructing the discovery of a solution to the disease. It is currently considered that the chances of success of therapy may increase if the tumor cells are selectively removed before they can evolve to their mature stages up to metastases production. Therefore, novel and more sensitive diagnostic tools are being developed, with the aim of improving the early and noninvasive detection of rising malignancies and the accuracy of tumor tissue localization. Meanwhile, there is an emerging use of targeted therapies in oncology, depending on the expression of specific proteins or genes present in tumor cells. Among the molecular targets considered for the treatment of breast cancer cells so far, we chose to focus on examples involving overexpression and/or gene amplification of “Human Epidermal growth factor Receptor 2” (HER2) protein. In current studies, various types of nanoparticles conjugated with the anti-HER2 monoclonal antibody, the so-called “trastuzumab”, are investigated extensively due to promising results in biological and preclinical applications aimed at improving the treatment of breast cancer. In this paper, we present a critical review of the preparation and use of different kinds of trastuzumab-functionalized nanoparticles, with an emphasis on the therapeutic and diagnostic (theranostic) potential of this generation of hybrid nanoparticles, exploiting the multifaceted mechanisms of action of trastuzumab against malignant cells." @default.
• W2075407107 created "2016-06-24" @default.
• W2075407107 creator A5002803474 @default.
• W2075407107 creator A5010927173 @default.
• W2075407107 creator A5011206324 @default.
• W2075407107 creator A5011668568 @default.
• W2075407107 creator A5015003245 @default.
• W2075407107 creator A5018083989 @default.
• W2075407107 creator A5028842822 @default.
• W2075407107 creator A5046028029 @default.
• W2075407107 creator A5049228752 @default.
• W2075407107 creator A5051511469 @default.
• W2075407107 creator A5067982846 @default.
• W2075407107 date "2010-08-01" @default.
• W2075407107 modified "2023-10-18" @default.
• W2075407107 title "HER2 targeting as a two-sided strategy for breast cancer diagnosis and treatment: Outlook and recent implications in nanomedical approaches" @default.
• W2075407107 cites W1492185019 @default.
• W2075407107 cites W170190512 @default.
• W2075407107 cites W1911376378 @default.
• W2075407107 cites W1964427001 @default.
• W2075407107 cites W1965686857 @default.
• W2075407107 cites W1967577948 @default.
• W2075407107 cites W1968578128 @default.
• W2075407107 cites W1968898129 @default.
• W2075407107 cites W1974024530 @default.
• W2075407107 cites W1975212714 @default.
• W2075407107 cites W1975480898 @default.
• W2075407107 cites W1976117858 @default.
• W2075407107 cites W1978907534 @default.
• W2075407107 cites W1983845908 @default.
• W2075407107 cites W1991321767 @default.
• W2075407107 cites W1993378158 @default.
• W2075407107 cites W1993659078 @default.
• W2075407107 cites W1993860023 @default.
• W2075407107 cites W1993985685 @default.
• W2075407107 cites W1994296373 @default.
• W2075407107 cites W1995242599 @default.
• W2075407107 cites W1995269182 @default.
• W2075407107 cites W1995842096 @default.
• W2075407107 cites W1996280453 @default.
• W2075407107 cites W1997215642 @default.
• W2075407107 cites W1999140453 @default.
• W2075407107 cites W2001018320 @default.
• W2075407107 cites W2001447115 @default.
• W2075407107 cites W2002980144 @default.
• W2075407107 cites W2003934359 @default.
• W2075407107 cites W2004490932 @default.
• W2075407107 cites W2004836788 @default.
• W2075407107 cites W2007073167 @default.
• W2075407107 cites W2009886463 @default.
• W2075407107 cites W2009886857 @default.
• W2075407107 cites W2012495753 @default.
• W2075407107 cites W2013768689 @default.
• W2075407107 cites W2014390504 @default.
• W2075407107 cites W2014457594 @default.
• W2075407107 cites W2014623805 @default.
• W2075407107 cites W2015921952 @default.
• W2075407107 cites W2016278775 @default.
• W2075407107 cites W2016399234 @default.
• W2075407107 cites W2021038659 @default.
• W2075407107 cites W2022271925 @default.
• W2075407107 cites W2023622490 @default.
• W2075407107 cites W2024651005 @default.
• W2075407107 cites W2024942244 @default.
• W2075407107 cites W2028298372 @default.
• W2075407107 cites W2029335572 @default.
• W2075407107 cites W2030855909 @default.
• W2075407107 cites W2033020296 @default.
• W2075407107 cites W2033488181 @default.
• W2075407107 cites W2033639000 @default.
• W2075407107 cites W2033778299 @default.
• W2075407107 cites W2034091339 @default.
• W2075407107 cites W2035159186 @default.
• W2075407107 cites W2035954535 @default.
• W2075407107 cites W2036969572 @default.
• W2075407107 cites W2038037578 @default.
• W2075407107 cites W2039609199 @default.
• W2075407107 cites W2040343091 @default.
• W2075407107 cites W2043009832 @default.
• W2075407107 cites W2044127957 @default.
• W2075407107 cites W2045118139 @default.
• W2075407107 cites W2045723481 @default.
• W2075407107 cites W2047006595 @default.
• W2075407107 cites W2052144389 @default.
• W2075407107 cites W2052689139 @default.
• W2075407107 cites W2052745039 @default.
• W2075407107 cites W2055944585 @default.
• W2075407107 cites W2058620780 @default.
• W2075407107 cites W2059411043 @default.
• W2075407107 cites W2062069198 @default.
• W2075407107 cites W2063575064 @default.
• W2075407107 cites W2067094759 @default.
• W2075407107 cites W2068071851 @default.
• W2075407107 cites W2070732456 @default.
• W2075407107 cites W2071289226 @default.
• W2075407107 cites W2072333351 @default.
• W2075407107 cites W2073689789 @default.
• W2075407107 cites W2074954932 @default.

• next